Sarver Vrooman Wealth Advisors »

Heron Therapeutics shares owned by Sarver Vrooman Wealth Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Sarver Vrooman Wealth Advisors from 13F filings

Historical chart of Sarver Vrooman Wealth Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Sarver Vrooman Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Sarver Vrooman Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1 1 1.00

More positions owned by Sarver Vrooman Wealth Advisors

Ishares Etf Tr Ibonds Dec 2031 Trem Corporate Etf (IBDW)
Schwab Us Dividend Etf Equity Etf (SCHD)
Ishares Tr Etf Ibonds Dec 2026 Term Corp Etf (IBDR)
Wisdomtree Us Qual Etf Dividend Growth Fund Etf (DGRW)
Xtrackers Msci Eafe Etf Equity Etf (DBEF)
Ishares Edge Msci Etf Min Vol Usa Etf Etf (USMV)
Microsoft Corp Stock (MSFT)
Palantir Technologies Inc Cl A Stock (PLTR)
Apple Stock (AAPL)
Spdr S&p 500 Trust Etf Etf (SPY)
Invesco Self-indexed Etf Fd Tr Bulletshares 2030 Mun Fd Etf Etf (BSMU)
Invesco Exch Traded Etf Self Indexed Fd Tr Bulletshares 2027 Mun Bd Etf (BSMR)
Invesco Qqq Tr Etf Unit Ser 1 Etf (QQQ)
Nvidia Corp Stock (NVDA)
Ishares Tr Ibonds Etf Dec 2034 Term Corporate Etf (IBDZ)

View all positions for Sarver Vrooman Wealth Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics